delivered in GSK’s Ellipta dry powder inhaler used across the company’s portfolio of inhaled COPD drugs. It was first approved in September last year for the long-term, once-daily, maintenance ...
It contains an inhaled corticosteroid, a long-acting muscarinic antagonist and a long-acting beta2-adrenergic agonist, delivered once daily in GSK’s Ellipta dry powder inhaler, which is used ...
Umeclidinium 62.5mcg; per inhalation; dry pwd for oral inhalation; contains lactose. Incruse Ellipta should be stored ... allergy after inhalation of other powder medications containing lactose ...
Meanwhile GSK's lead inhalers include Trelegy Ellipta, projected to bring $ ... choosing the best therapy for each patient. "Are dry powder inhalers the key to sustainable respiratory care?" ...